PMC:7441788 / 15918-16194
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T99 | 49-57 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T174 | 152-154 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T207 | 3-21 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T208 | 200-202 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T209 | 238-240 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T128 | 3-21 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
T129 | 200-202 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T130 | 238-240 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T102 | 49-57 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T118 | 59-140 | Sentence | denotes | Author (Reference) Study design Patients Treatment Outcomes Advantage Limitations |
T119 | 141-156 | Sentence | denotes | Gao et al [48]. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
642 | 91-99 | Species | denotes | Patients | Tax:9606 |
657 | 200-202 | Chemical | denotes | CQ | MESH:D002738 |
658 | 238-240 | Chemical | denotes | CQ | MESH:D002738 |
735 | 3-21 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
736 | 23-26 | Chemical | denotes | HCQ | MESH:D006886 |
737 | 49-57 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T92 | 49-57 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
642 | 91-99 | Species | denotes | Patients | Tax:9606 |
657 | 200-202 | Chemical | denotes | CQ | MESH:D002738 |
658 | 238-240 | Chemical | denotes | CQ | MESH:D002738 |
735 | 3-21 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
736 | 23-26 | Chemical | denotes | HCQ | MESH:D006886 |
737 | 49-57 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T118 | 59-140 | Sentence | denotes | Author (Reference) Study design Patients Treatment Outcomes Advantage Limitations |
T119 | 141-156 | Sentence | denotes | Gao et al [48]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32496926-32074550-132195702 | 152-154 | 32074550 | denotes | 48 |